MedPath

Digestive Endoscopy Suite Radiation Controlling Protective Strategies

Early Phase 1
Completed
Conditions
Radiation Exposure
Registration Number
NCT02063841
Lead Sponsor
Yale University
Brief Summary

ERCP is associated with radiation exposure to the endoscopist and staff, which may be significant at high volume programs despite the use of lead aprons. We hypothesize that draping of the fluoroscopy image intensifier may significantly reduce staff radiation exposure and help achieve implementation of the ALARA (As Low As Reasonably Achievable) principle.

Detailed Description

A total of 100 consecutive ERCP procedures were randomly assigned to the radiation-attenuating or sham drape in a 1:1 ratio. There were 2 subjects, the endoscopists performing ERCP and the nurse assisting in the procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • All the ERCP procedures done by the same endoscopist and nurse are enrolled
  • Patients age >19
Exclusion Criteria
  • Fluoroscopic procedures other than ERCP were excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Amount of radiation exposureLength of Endoscopic retrograde cholangiopancreatography, average 5 minutes

Comparing the use of a lead-free protective drape containing bismuth and antimony and a sterile sham protective drape, radiation dose (RD) was measured at 3 different sites (endoscopist's eye (1) and thyroid (2), and assisting nurse's thyroid (3)) with personal dosimeters placed outside of eyeglass frames and the thyroid shield. The unit of measurement is each event. The subject was subjected to radiation during 100 Endoscopic retrograde cholangiopancreatography procedures.Both groups used standard of care lead protection.

Secondary Outcome Measures
NameTimeMethod
Estimate cumulative annual radiation riskLength of Endoscopic retrograde cholangiopancreatography, average 5 minutes

Comparing the use of a lead-free protective drape containing bismuth and antimony and a sterile sham protective drape, radiation dose (RD) was measured at 3 different sites (endoscopist's eye (1) and thyroid (2), and assisting nurse's thyroid (3)) with personal dosimeters placed outside of eyeglass frames and the thyroid shield. The unit of measurement is each event. The subject was subjected to radiation during 100 endoscopic retrograde cholangiopancreatography procedures. The cumulative estimated annual absorbed radiation dose was estimated from the data collected during the study time frame.

Trial Locations

Locations (1)

Endoscopy Center, Smilow Cancer Center, Yale New Haven Hospital

🇺🇸

New Have, Connecticut, United States

Endoscopy Center, Smilow Cancer Center, Yale New Haven Hospital
🇺🇸New Have, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.